Rentschler focuses on biotechnology

17 July 2008

Rentschler will invest another €14 million in the expansion of Rentschler Biotechnologie GmbH at its Laupheim, Germany site. The company has recently has recently completed a €50m investment in biotechnological development and production facilities.

Work will start later this year for the new construction of a logistics centre and the expansion of the administrative building in Erwin-Rentschler-Straße in Laupheim. In the logistics centre, a high-rise warehouse, several cold warehouses, an incoming goods department, a dispatch area and the company's transport fleet will be located.

The move into the new buildings is planned for end of 2009. This step will concentrate all of Rentschler's biotech activities at one site and thus provides the frame for further growth.

Within the scope of this business concentration on the development and manufacture of biopharmaceutical drug products, Dr Rentschler Holding GmbH & Co. KG has sold all of the shares of Rentschler Pharma GmbH to Riemser Arzneimittel AG in Greifswald/Isle of Riems, Eastern Germany.

Riemser is planning to further expand its business division contract manufacture from the Laupheim site. In this connection Rentschler Pharma GmbH will be renamed to Riemser Speciality Production GmbH.

Your browser does not support inline frames or is currently configured not to display inline frames.	Your browser does not support inline frames or is currently configured not to display inline frames. Rentschler focuses on biotechnology 17 July 2008 Rentschler will invest another €14 million in the expansion of Rentschler Biotechnologie GmbH at its Laupheim, Germany site. The company has recently has recently completed a €50m investment in biotechnological development and production facilities. Work will start later this year for the new construction of a logistics centre and the expansion of the administrative building in Erwin-Rentschler-Straße in Laupheim. In the logistics centre, a high-rise warehouse, several cold warehouses, an incoming goods department, a dispatch area and the company's transport fleet will be located. The move into the new buildings is planned for end of 2009. This step will concentrate all of Rentschler's biotech activities at one site and thus provides the frame for further growth. Within the scope of this business concentration on the development and manufacture of biopharmaceutical drug products, Dr Rentschler Holding GmbH & Co. KG has sold all of the shares of Rentschler Pharma GmbH to Riemser Arzneimittel AG in Greifswald/Isle of Riems, Eastern Germany. Riemser is planning to further expand its business division contract manufacture from the Laupheim site. In this connection Rentschler Pharma GmbH will be renamed to Riemser Speciality Production GmbH. Your browser does not support inline frames or is currently configured not to display inline frames. To top	Your browser does not support inline frames or is currently configured not to display inline frames.